|
|
||||||||
From the Departments of Psychiatry (Drs. Cherner, Marcotte, Heaton, and Grant) and Neurosciences (Drs. Masliah and Ellis), University of California at San Diego; San Diego State University/University of California at San Diego Joint Doctoral Program in Clinical Psychology (D.J. Moore); and VA San Diego Health Care System (Dr. Grant), CA.
Address correspondence and reprint requests to Dr. Mariana Cherner, 150 W. Washington St., 2nd floor, San Diego, CA 92103; e-mail: mcherner{at}ucsd.edu
Objective: To investigate the value of antemortem cognitive functioning in predicting postmortem evidence of HIV encephalitis (HIVE).
Methods: Thirty-nine subjects were assessed during life with a comprehensive neuropsychological battery and went on to autopsy within 18 months of testing. Cognitive impairment was determined by blind clinical ratings, based on demographically corrected test scores. Presence of HIVE was based on postmortem immunocytochemical detection of the viral protein gp41 or by measurement of HIV RNA by PCR in multiple brain areas as well as by histopathologic evidence such as microgliosis, presence of multinucleated giant cells, and myelin pallor in several brain regions.
Results: The sensitivity and specificity of neurocognitive impairment in detecting the occurrence of HIVE were 67 and 92%. Eighteen of 19 subjects with antemortem neurocognitive impairment had evidence of HIV-related brain disease (positive predictive value = 95%).
Conclusion: Neuropsychological assessment can help select HIV-positive patients for treatment of CNS disease.
This article has been cited by other articles:
![]() |
J. Liu, N. Gong, X. Huang, A. D. Reynolds, R. L. Mosley, and H. E. Gendelman Neuromodulatory Activities of CD4+CD25+ Regulatory T Cells in a Murine Model of HIV-1-Associated Neurodegeneration J. Immunol., March 15, 2009; 182(6): 3855 - 3865. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, J. H. Zheng, M. Zhao, S. Lee, and H. Goldstein Increased In Vivo Activation of Microglia and Astrocytes in the Brains of Mice Transgenic for an Infectious R5 Human Immunodeficiency Virus Type 1 Provirus and for CD4-Specific Expression of Human Cyclin T1 in Response to Stimulation by Lipopolysaccharides J. Virol., June 1, 2008; 82(11): 5562 - 5572. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antinori, G. Arendt, J. T. Becker, B. J. Brew, D. A. Byrd, M. Cherner, D. B. Clifford, P. Cinque, L. G. Epstein, K. Goodkin, et al. Updated research nosology for HIV-associated neurocognitive disorders Neurology, October 30, 2007; 69(18): 1789 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Wachtman, R. L. Skolasky, P. M. Tarwater, D. Esposito, G. Schifitto, K. Marder, M. P. McDermott, B. A. Cohen, A. Nath, N. Sacktor, et al. Platelet Decline: An Avenue for Investigation Into the Pathogenesis of Human Immunodeficiency Virus Associated Dementia Arch Neurol, September 1, 2007; 64(9): 1264 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gongvatana, S. P. Woods, M. J. Taylor, O. Vigil, I. Grant, and The HNRC Group Semantic Clustering Inefficiency in HIV-Associated Dementia J Neuropsychiatry Clin Neurosci, February 1, 2007; 19(1): 36 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Thompson, R. A. Dutton, K. M. Hayashi, A. W. Toga, O. L. Lopez, H. J. Aizenstein, and J. T. Becker Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline PNAS, October 25, 2005; 102(43): 15647 - 15652. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Strain, S. Letendre, S. K. Pillai, T. Russell, C. C. Ignacio, H. F. Gunthard, B. Good, D. M. Smith, S. M. Wolinsky, M. Furtado, et al. Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy J. Virol., February 1, 2005; 79(3): 1772 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Persidsky and H. E. Gendelman Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection J. Leukoc. Biol., November 1, 2003; 74(5): 691 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Marcotte, R. Deutsch, J. A. McCutchan, D. J. Moore, S. Letendre, R. J. Ellis, M. R. Wallace, R. K. Heaton, and I. Grant Prediction of Incident Neurocognitive Impairment by Plasma HIV RNA and CD4 Levels Early After HIV Seroconversion Arch Neurol, October 1, 2003; 60(10): 1406 - 1412. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |